Core Laboratories (NYSE:CLB) Shares Up 5.9% – What’s Next?

Shares of Core Laboratories Inc. (NYSE:CLB) traded up 5.9% during trading on Wednesday . The company traded as high as $12.20 and last traded at $12.0870. Approximately 264,549 shares changed hands during mid-day trading, a decline of 54% from the average session volume of 573,573 shares. The stock had previously closed at $11.41.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on CLB. Weiss Ratings lowered shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, June 24th. Wall Street Zen downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research note on Saturday, July 4th. One research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Core Laboratories has a consensus rating of “Reduce”.

Core Laboratories Price Performance

The business has a 50-day moving average of $12.38 and a two-hundred day moving average of $15.53. The company has a current ratio of 2.05, a quick ratio of 1.50 and a debt-to-equity ratio of 0.42. The firm has a market cap of $543.93 million, a P/E ratio of 18.15, a price-to-earnings-growth ratio of 2.89 and a beta of 1.00.

Core Laboratories (NYSE:CLB) last posted its earnings results on Wednesday, April 29th. The oil and gas company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. Core Laboratories had a return on equity of 11.52% and a net margin of 5.94%.The firm had revenue of $121.80 million during the quarter, compared to the consensus estimate of $122.99 million. During the same period last year, the company earned $0.14 earnings per share. The business’s quarterly revenue was down 1.4% on a year-over-year basis. Core Laboratories has set its Q2 2026 guidance at 0.060-0.120 EPS. On average, sell-side analysts anticipate that Core Laboratories Inc. will post 0.53 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, June 1st. Investors of record on Monday, May 11th were issued a $0.01 dividend. This represents a $0.04 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date was Monday, May 11th. Core Laboratories’s dividend payout ratio (DPR) is 6.15%.

Institutional Investors Weigh In On Core Laboratories

Several hedge funds have recently added to or reduced their stakes in CLB. Summit Securities Group LLC acquired a new position in Core Laboratories in the 1st quarter valued at approximately $31,000. Aster Capital Management DIFC Ltd bought a new position in shares of Core Laboratories during the fourth quarter valued at $34,000. CWM LLC lifted its holdings in shares of Core Laboratories by 36.1% during the fourth quarter. CWM LLC now owns 2,516 shares of the oil and gas company’s stock worth $40,000 after purchasing an additional 668 shares during the period. Quarry LP lifted its holdings in shares of Core Laboratories by 118.1% during the third quarter. Quarry LP now owns 2,953 shares of the oil and gas company’s stock worth $36,000 after purchasing an additional 1,599 shares during the period. Finally, Hantz Financial Services Inc. lifted its holdings in shares of Core Laboratories by 124.7% during the fourth quarter. Hantz Financial Services Inc. now owns 3,177 shares of the oil and gas company’s stock worth $51,000 after purchasing an additional 1,763 shares during the period. 97.81% of the stock is currently owned by institutional investors and hedge funds.

About Core Laboratories

Core Laboratories N.V. is a global provider of proprietary and patented reservoir description and production enhancement services to the oil and gas industry. The company applies specialized expertise in core and fluid analysis, advanced petrophysical interpretation, and reservoir engineering to optimize hydrocarbon recovery. By integrating laboratory testing with field services and digital analytics, Core Laboratories delivers insights that help operators maximize production and extend the life of their assets.

The company’s portfolio spans two primary service lines: reservoir description and production enhancement.